Kyle Gano Neurocrine Biosciences Inc (NBIX) insider trading activity

Kyle Gano is Chief Business Development Off of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 135,166 shares of NBIX, which is worth approximately $16.2 Million. The most recent transaction as insider was on Feb 13, 2024, when has been sold 1,352 shares (Common Stock) at a price of $132.89 per share, resulting in proceeds of $179,667. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135K

0% 3M change

3.77% 12M change

Total Value Held $16.2 Million

Kyle Gano Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2024	SELL Open market or private sale	$179,667 $132.89 p/Share	1,352 Reduced 0.99%	135,166 Common Stock
Feb 08 2024	SELL Open market or private sale	$131,516 $134.2 p/Share	980 Reduced 0.73%	133,952 Common Stock
Feb 06 2024	SELL Open market or private sale	$227,519 $142.2 p/Share	1,600 Reduced 1.19%	133,072 Common Stock
Jan 31 2024	SELL Open market or private sale	$216,818 $140.7 p/Share	1,541 Reduced 1.16%	131,635 Common Stock
Jan 02 2024	SELL Open market or private sale	$9,859,500 $131.46 p/Share	75,000 Reduced 36.54%	130,250 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$1,469,250 $19.59 p/Share	75,000 Added 35.48%	136,366 Common Stock
Aug 21 2023	SELL Open market or private sale	$228,998 $107.41 p/Share	2,132 Reduced 1.61%	130,250 Common Stock
Feb 08 2023	SELL Open market or private sale	$101,910 $103.99 p/Share	980 Reduced 0.76%	128,096 Common Stock
Feb 07 2023	SELL Open market or private sale	$1,476,296 $102.35 p/Share	14,424 Reduced 10.18%	127,216 Common Stock
Feb 06 2023	SELL Open market or private sale	$169,024 $105.64 p/Share	1,600 Reduced 1.38%	114,257 Common Stock
Jan 31 2023	SELL Open market or private sale	$169,479 $109.98 p/Share	1,541 Reduced 1.35%	112,820 Common Stock
Feb 08 2022	SELL Open market or private sale	$78,077 $79.67 p/Share	980 Reduced 0.87%	111,173 Common Stock
Feb 07 2022	SELL Open market or private sale	$476,484 $80.76 p/Share	5,900 Reduced 5.08%	110,294 Common Stock
Jan 05 2022	SELL Open market or private sale	$2,416,743 $85.5 p/Share	28,266 Reduced 21.21%	104,984 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$244,784 $8.66 p/Share	28,266 Added 17.5%	133,250 Common Stock
Feb 08 2021	SELL Open market or private sale	$431,527 $116.85 p/Share	3,693 Reduced 3.4%	104,768 Common Stock
Feb 05 2021	SELL Open market or private sale	$304,991 $113.93 p/Share	2,677 Reduced 2.6%	100,439 Common Stock
Nov 12 2020	SELL Open market or private sale	$204,778 $90.73 p/Share	2,257 Reduced 2.25%	98,028 Common Stock

Kyle Gano

Chief Business Development Off

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account